049180.Kq
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company's capital structure is characterized by a high debt-to-equity ratio of 1.56, indicating a significant reliance on debt financing. The liquidity position is further strained by a current ratio of 0.9, suggesting that the company's current assets are insufficient to cover its current liabilities. The negative net cash position after subtracting total debt highlights the company's liquidity risk.
Profitability metrics reveal a challenging financial situation. The company reported a net loss of 2,235,730,420 KRW, with a return on equity of -26.68% and a return on assets of -3.67%. These figures are below the industry median for profitability, indicating that the company is underperforming relative to its peers in terms of generating returns for shareholders and utilizing assets efficiently.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification increases the company's exposure to market-specific risks and could limit its ability to grow through new markets or product lines.
The company's growth trajectory is uncertain, with a net loss in the most recent fiscal year and negative operating and free cash flows. The absence of positive cash flow from operations and the lack of capital expenditure suggest that the company is not investing in future growth. Analysts have reported a last actual EPS of -1,735.00 KRW, which further underscores the company's financial challenges.
The company faces several risk factors, including liquidity risk due to its high debt load and negative cash flow. The risk assessment indicates a medium level of liquidity risk and a low probability of dilution in the near term. However, the company's negative net income and operating cash flow suggest that it may need to raise additional capital in the future, which could lead to dilution for existing shareholders.
Recent events, as reflected in the financial data, include a significant net loss and negative cash flows, which are indicative of operational and financial distress. The company has not disclosed any recent strategic initiatives or capital-raising activities in the provided data, which may suggest a lack of immediate plans to address its financial challenges.
- The company is experiencing significant financial distress, as evidenced by a net loss and negative cash flows.
- The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.56.
- The company's profitability metrics are below industry medians, indicating underperformance relative to peers.
- The company lacks geographic and segment diversification, increasing its exposure to market-specific risks.
- The company's liquidity position is weak, with a current ratio of 0.9 and a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 049180.KQ Market data — financials · 2026-05-26
- Cellumed Co Ltd Market data — analyst estimates · 2026-05-26